Table 1

 Mean (SE) baseline characteristics of study subjects

Control group(n = 8)CPAP group(n = 10)
BMI, body mass index; HF, heart failure; ICM, ischaemic cardiomyopathy; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; ESS, Epworth Sleepiness Scale; ACE, angiotensin converting enzyme.
Age (years)60.3 (4.1)57.6 (2.2)
Sex (M:F)7:19:1
BMI (kg/m2)35.1 (3.7)28.3 (1.3)
Cause of HF
    ICM, n (%)6 (75%)6 (60%)
    Non-ICM, n (%)2 (25%)4 (40%)
LVEF (%)34.1 (3.0)27.6 (3.4)
ESS5.5 (1.1)7.5 (0.9)
Medications
    Digoxin, n (%)5 (63%)9 (90%)
    Diuretics, n (%)6 (75%)6 (60%)
    ACE inhibitors, n (%)8 (100%)8 (80%)
    β blockers, n (%)5 (63%)9 (90%)